Brain Advance Access originally published online on May 9, 2006
Brain 2006 129(7):1748-1757; doi:10.1093/brain/awl103
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease
Department of Neurology and Neurosurgery, Neuroscience Area, Clinica Universitaria and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra Pamplona, Spain 1 Present addresses: Section of Neurology, Hospital de Fuenlabrada Madrid, Spain 2 Section of Neurology, Hospital Universitario de Guadalajara Guadalajara, Spain
Correspondence to: José A. Obeso, Department of Neurology and Neurosurgery, Clinica Universitaria, Avenida de Pio XII 36, Pamplona 31008, Spain E-mail: jobeso{at}unav.es
The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson's disease is not well understood. We have recorded local field potentials (LFP) from macroelectrodes implanted in the subthalamic nucleus (STN) of 14 patients with Parkinson's disease following surgical treatment with deep brain stimulation. Patients were studied in the Off medication state and in the On motor state after administration of levodopacarbidopa (po) or apomorphine (sc) that elicited dyskinesias in 11 patients. The logarithm of the power spectrum of the LFP in selected frequency bands (410, 1130 and 6080 Hz) was compared between the Off and On medication states. A peak in the 1130 Hz band was recorded in the Off medication state and reduced by 45.2% (P < 0.001) in the On state. The On was also associated with an increment of 77. 6% (P < 0.001) in the 410 Hz band in all patients who showed dyskinesias and of 17.8% (P < 0.001) in the 6080 Hz band in the majority of patients. When dyskinesias were only present in one limb (n = 2), the 410 Hz peak was only recorded in the contralateral STN. These findings suggest that the 410 Hz oscillation is associated with the expression of LID in Parkinson's disease.
Key Words: dyskinesias; subthalamic nucleus; oscillatory activity; Parkinson's disease
Abbreviations: DA, dopamine; DBS, deep brain stimulation; DID, dyskinesiaimprovementdyskinesia; GPi, globus pallidus pars interna; FFT, fast Fourier transformation; LID, levodopa-induced dyskinesias; LFP, local field potentials; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; STN, subthalamic nucleus
Received October 12, 2005. Revised December 24, 2005. Accepted March 28, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Schuster, A. Nadjar, J. T. Guo, Q. Li, C. Ittrich, B. Hengerer, and E. Bezard The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease J. Neurosci., April 23, 2008; 28(17): 4311 - 4316. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lalo, S. Thobois, A. Sharott, G. Polo, P. Mertens, A. Pogosyan, and P. Brown Patterns of Bidirectional Communication between Cortex and Basal Ganglia during Movement in Patients with Parkinson Disease J. Neurosci., March 19, 2008; 28(12): 3008 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Androulidakis, A. A. Kuhn, C. Chu Chen, P. Blomstedt, F. Kempf, A. Kupsch, G.-H. Schneider, L. Doyle, P. Dowsey-Limousin, M. I. Hariz, et al. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease Brain, February 1, 2007; 130(2): 457 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weinberger, N. Mahant, W. D. Hutchison, A. M. Lozano, E. Moro, M. Hodaie, A. E. Lang, and J. O. Dostrovsky Beta Oscillatory Activity in the Subthalamic Nucleus and Its Relation to Dopaminergic Response in Parkinson's Disease J Neurophysiol, December 1, 2006; 96(6): 3248 - 3256. [Abstract] [Full Text] [PDF] |
||||


